Annual Long Term Debt
$37.00 K
-$214.00 K-85.26%
December 31, 2023
Summary
- As of February 12, 2025, SPRY annual long term debt is $37.00 thousand, with the most recent change of -$214.00 thousand (-85.26%) on December 31, 2023.
- During the last 3 years, SPRY annual long term debt has fallen by -$7.42 million (-99.50%).
- SPRY annual long term debt is now -99.50% below its all-time high of $7.46 million, reached on December 1, 2020.
Performance
SPRY Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, SPRY quarterly long term debt is $0.00, unchanged on September 30, 2024.
- Over the past year, SPRY quarterly long term debt has stayed the same.
- SPRY quarterly long term debt is now -100.00% below its all-time high of $5.41 million, reached on December 1, 2021.
Performance
SPRY Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
SPRY Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.3% | 0.0% |
| 3 y3 years | -99.5% | 0.0% |
| 5 y5 years | -99.5% | 0.0% |
SPRY Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -99.3% | at low | -100.0% | at low |
| 5 y | 5-year | -99.5% | at low | -100.0% | at low |
| alltime | all time | -99.5% | at low | -100.0% | at low |
ARS Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $37.00 K | $37.00 K(-59.8%) |
| Sep 2023 | - | $92.00 K(-37.0%) |
| Jun 2023 | - | $146.00 K(-26.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $199.00 K(-20.7%) |
| Dec 2022 | $251.00 K(-95.4%) | $251.00 K(-92.9%) |
| Jun 2022 | - | $3.52 M(-35.0%) |
| Dec 2021 | $5.41 M(-27.5%) | - |
| Dec 2021 | - | $5.41 M |
| Dec 2020 | $7.46 M | - |
FAQ
- What is ARS Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual long term debt year-on-year change?
- What is ARS Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly long term debt year-on-year change?
What is ARS Pharmaceuticals annual long term debt?
The current annual long term debt of SPRY is $37.00 K
What is the all time high annual long term debt for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual long term debt is $7.46 M
What is ARS Pharmaceuticals annual long term debt year-on-year change?
Over the past year, SPRY annual long term debt has changed by -$214.00 K (-85.26%)
What is ARS Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of SPRY is $0.00
What is the all time high quarterly long term debt for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly long term debt is $5.41 M
What is ARS Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, SPRY quarterly long term debt has changed by $0.00 (0.00%)